• 1
    Cook AK, Breitschwerdt EB, Levine JF, et al. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985–1990). J Am Vet Med Assoc 1993; 203 (5): 673679.
  • 2
    Hess RS, Saunders HM, Van Winkle TJ, et al. Clinical, clinicopathologic, radiographic, and ultrasonagraphic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986–1995). J Am Vet Med Assoc 1998; 213 (5): 665670.
  • 3
    Ruaux CG, Atwell RB. General practice attitudes toward the treatment of spontaneous canine acute pancreatitis. Austr Vet Pract 1998; 28: 6774.
  • 4
    Isenmann R, Rau B, Berger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86 (8): 10201024.
  • 5
    Vensentini S, Bassi C, Talamini G, et al. Prospective comparison of C-reactive protein level, Ranson score, and contrast enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993; 80 (6): 755757.
  • 6
    Puolakkainen P, Valtonen V, Paananen A, et al. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987; 28: 764771.
  • 7
    Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177181.
  • 8
    Buchler M, Malfertheiner P, Schoetensack C, et al. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol 1986; 1 (3–4): 227235.
  • 9
    Pezzilli R, Melzid'Eril GV, Morselli-Labate AM, et al. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000; 45 (6): 10721078.
  • 10
    Viedma JA, Perez-Mateo M, Agullo J, et al. Inflammatory response on the early prediction of severity in human acute pancreatitis. Gut 1994; 35 (6): 822827.
  • 11
    De Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83 (8): 10711075.
  • 12
    Uhl W, Buchler M, Malfertheiner P, et al. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6 (3): 253259.
  • 13
    Yamashita K, Fujunaga T, Miyamoto T, et al. Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. J Vet Med Sci 1994; 56: 487492.
  • 14
    Berton G, Cordiano R, Palmieri R, et al. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J 2003; 145 (6): 10941101.
  • 15
    Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123 (6): 20432049.
  • 16
    Dervenis C, Johnson CD, Bassi C, et al. Consensus document: diagnosis, objective assessment of severity, and management of acute pancreatitis: Santorini Consensus Conference. Int J Pancreatol 1999; 25: 195210.
  • 17
    Burton SA, Honor DJ, Mackenzie AL, et al. C-reactive protein concentrations in dogs with inflammatory leukograms. Am J Vet Res 1994; 55 (5): 613618.
  • 18
    Conner JG, Eckersall PD. Acute phase response in the dog following surgical trauma. Res Vet Sci 1988; 45: 107110.
  • 19
    Otabe K, Ito T, Sugimoto T, Yamamoto S. C-reactive protein (CRP) measurement in canine serum following experimentally-induced acute gastric mucosal injury. Lab Anim 2000; 34: 434438.
  • 20
    Liu Q, Djuricin G, Nathan C, et al. The effect of interleukin-6 on bacterial translocation in acute canine pancreatitis. Int J Pancreatol 2000; 27 (2): 157165.
  • 21
    Otabe K, Sugimoto T, Jinbo T, et al. Physiological levels of C-reactive protein in normal canine sera. Vet Res Commun 1998; 22: 7785.
  • 22
    Yamamoto S, Shida T, Miyaji H, et al. Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas. Vet Res Commun 1993; 17: 8593.
  • 23
    Jergens AE, Schreiner CA, Frank DE, et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003; 17 (3): 291297.
  • 24
    Caspi D, Snel FWJJ, Batt RM, et al. C-reactive protein in dogs. Am J Vet Res 1987; 48: 919921.
  • 25
    Otabe K, Ito T, Sugimoto T, et al. C-reactive protein (CRP) measurement in canine serum following experimentally-induced acute gastric mucosal injury. Lab Anim 2000; 34: 434438.
  • 26
    Shimada T, Ishida Y, Shimizu M, et al. Monitoring C-reactive protein in Beagle dogs experimentally inoculated with Ehrlichia canis. Vet Res Commun 2002; 26: 171177.
  • 27
    Martinez-Subiela S, Bernal LJ, Ceron JJ. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment. Am J Vet Res 2003; 64: 10211026.
  • 28
    Kjelgaard-hansen M, Kristensen AT, Jensen AL. Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum. J Vet Med 2003; 50: 164168.
  • 29
    Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431435.